Two main findings emerged: A small change in the GLP1R gene (rs10305420) was significantly associated with greater weight loss
This can include emotional eating, stress eating, and distress eating
These are often located at hospitals or public health facilities
The FDA has approved Wegovy (semaglutide 2.4 mg), Zepbound (tirzepatide), and Saxenda (liraglutide 3 mg) for chronic weight management in adults with obesity (BMI 30 kg/m) or overweight (BMI 27 kg/m) with at least one weight-related comorbidity
Some users report new-onset insomnia, low mood, or sleep-onset anxiety, especially when food becomes emotionally charged
For example, these factors lower the threshold for clot formation: Coronary artery disease with plaque Diabetic vascular disease Chronic inflammatory disorders Prior thrombosis Dehydration, immobilization after surgery, or the combined use of drugs that affect clotting can further increase risk